November | 2012 | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
QDEL 03.31.2022 Earnings Call Script
Abbott Labs Deal Headaches Go Beyond Bad Luck - Bloomberg
Abbott files complaint to end Alere acquisition deal
Mml Series Investment Fund Ii 2013 Semi-Annual Certified Shareholder Report N-CSRS
2009 General Corporation Tax Allocation Percentage ... - NYC.gov
Abbott Labs Deal Headaches Go Beyond Bad Luck - Bloomberg
Calaméo - Healthmedicinet Com I 2016 12
HRM Asia Magazine November/December 2021 Issue by HRM Asia - Issuu
Payer Roundup—Insurance brokers offered gifts, cash for selling employer health plans | Fierce Healthcare
Abbott subsidiary Alere pays $160M to settle false Medicare claims, diabetes kickbacks | Fierce Biotech
Global Health Governance
VOLUME 37 NUMBER 11
Abbott Proceeding with Alere Acquisition, at a Lower Price, as Legal Wrangle Ends
Abbott Labs Deal Headaches Go Beyond Bad Luck - Bloomberg
Abbott Labs Deal for Alere Shows Good Timing - Bloomberg
MassMutual Premier Funds
Abbott moves ahead on St. Jude, Alere deals, but investors fret | Reuters
DEFM14A
BlackRock Funds II
Abbott and Alere, After Lawsuits, Agree to Make Up and Tie the Knot - The New York Times
Calaméo - The Boston Globe 07282016
